Australia-founded beverages maker Lyre’s has raised $11.5 million in seed funding with a view to helping non-alcoholic spirits follow in the footsteps of alternative protein
Chinese online-to-offline (O2O) medicine retailer Dingdang Kuaiyao has raised RMB1 billion ($150 million) in an extended Series B round featuring Dragon Gate Investment Partners.
Sequoia Capital India and US-based Flourish Ventures have led a $22.5 million Series A round for Bangladesh B2B platform ShopUp. It is both firms’ first investment in the country.
Australian alternative protein producer V2Food has raised a A$77 million ($55 million) Series B round featuring Sequoia Capital China and Temasek Holdings.
Shaonian Dedao, a Chinese education app for teenagers led by former CCTV host Quanlin Zhang, has raised RMB200 million ($29 million) in a Series B funding round led by Vision Knight Capital.
China’s 3H Health Investment has led a RMB450 million ($67 million) Series B round for local genetics-based drug discovery and therapeutics developer EdiGene.
Japanese videogame publishing company Thirdverse believes the time is right to bring virtual reality entertainment to the masses. VCs with expertise in the sector are beginning to agree
Hong Kong-based Zhaoke Ophthalmology Pharmaceutical (ZKO), a subsidiary of Lee’s Pharmaceutical, has raised a $145 million Series B round led by Hillhouse Capital and TPG Asia.
Japan’s Jafco has led an $8.5 million Series A round for local virtual reality (VR) game developer Thirdverse.
Having increased its Series A round to $30.5 million, Neuron Mobility is ramping up expansion of its e-scooter rental services, with Australia and New Zealand the immediate priorities
RevComm, a Japan-based voice recognition artificial intelligence (AI) technology provider, has closed its Series A round at JPY1.5 billion ($14.2 million) with support from several local VCs.
Inshorts, an Indian news aggregation app, has raised $35 million in funding led by Addition, an investment firm launched by Lee Fixel, who was previously involved in Tiger Global Management’s India deals.
Prosus Ventures, formerly a VC arm of South African media conglomerate Naspers, has led a $12 million Series B round for Pakistan ride-hailing and courier app Bykea.
Neuron Mobility, a Singapore-based e-scooter rental start-up, has secured $12 million in an extended Series A round as it accelerates expansion in Australia and New Zealand and prepares to enter the UK.
Green Monday, the Hong Kong plant-based food distributor behind the Green Common retail chain and OmniPork alternative meats, has raised its first institutional round of funding.
Hong Kong and US-based food tech investor Lever VC has confirmed five investments in alternative protein start-ups from its recently launched China fund.
GL Ventures, the China venture capital arm of Hillhouse Capital, has led a $147 million Series D round for Shanghai-based biotech developer InventisBio.
Matrix Partners China has led a $40 million Series B round for local robotics start-up Cyclone. Other investors include DCM, Lenovo Capital, Source Code Capital, and Renzhi Capital.
Playco, a Japan-headquartered mobile gaming start-up, has simultaneously formally launched operations and become a unicorn, raising $100 million in Series A funding at a valuation of $1 billion.
As social distancing and travel restrictions play havoc with traditional conferences, Airmeet has seen a spike in demand for its virtual alternatives. A Series A round duly followed
The Rise Fund, TPG’s impact investment vehicle, and Hong Kong conglomerate Swire Pacific have led a $70 million round for Green Monday Holdings, a Hong Kong plant-based protein provider.
Jungle Ventures and EV Growth lead $75 million round for Waresix, backing the company's integrated platform as a solution to Indonesia's logistics challenges
Addor Capital has led a RMB220 million ($32 million) Series B funding round for Hangzhou-based drug developer Sumgen Biotech.
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.